
Ryu Young-joon starts filling out his resignation form. Where should I go if I get out of Aizen?
In Korea, the status of Aizen company is very large and monopolize the pharmaceutical field, Aizen, so that only other pharmaceutical companies that are small companies that can be removed easily by Aizen company if considered dangerous for the development of the company Aizen in the future. There was nothing I could gain from going to such a place.
This is due to the lack of research infrastructure. Rosalin gives the answer, but it is up to Ryu to make it into the real world. Small companies do not have advanced equipment such as cell separators, lattice light field microscopes, or high-sic sequencers. Many obstacles are encountered when storing genetically modified organisms or human-derived samples that are needed for experiments.
It is very difficult to get permission for clinical trials. Above all, the big problem is that Aizen holds the domestic market and monopolizes it. I had it with all my might when I had liver cancer.
But there are few places overseas that can compete with Eisen - big pharmaceutical companies like Roche, Pfizer and Johnson & Johnson - big enough to fight the Aizen Company.
"Roche, Pfizer, Johnson & Johnson .." Ryu Young-joon, who was typing his resignation letter, stopped. I took my hand off the keyboard. Waita minute. Are they really better than Aizen?
I remember the bad things I heard in the past. The news was published by Independence on November 14, 2011. After deregulation of clinical trials in India in 2005, several Western multinational pharmaceutical companies, including Pfizer, conducted large clinical trials in India.
It goes without saying that clinical subjects are poor people and more problems are behind them. Minors are included. There are even those who do not know what to write. About 1,730 people died in three years due to the clinical trial and get compensation for people who died about 62 million/person. Although the case was revealed independently, the pharmaceutical company still has not received disciplinary action. Instead, he sued independently for the spread of the news.
What about Roche?
5,000 AIDS patients in South Korea have protested against Roche over the past few years. Because Roche doesn't sell the AIDS drug "Fuzeon" in Korea. The reason is because the unit price is low. Although the average Korean and U. S. revenues were doubled, Roche asked for the same price as the U. S. selling price.
Considering that Puzeon's annual net profit is already worth 1.15 Trillion, that's not very convincing. The profitability of multinational pharmaceutical companies is huge compared to the financial, manufacturing, and IT sectors.
Among Fortune 500 companies in 2002, only 10 pharmaceutical companies with their net income higher than the remaining 490 combined. On the one hand, it's natural. Who can do anything to earn 100 times the unit price of production when they sell drugs exclusively by mortgaging people's lives.
After all, for that reason, many AIDS patients in Korea die, become blind, or paralyzed. Some of the lucky patients received small amounts of Puzeon from international aid agencies.
Moreover, countries in Africa clearly do not have much money to buy the drug Aids, with this African government secretly in collaboration with the Indian government to make a copy of the drug Aids made by Roche. And sell it at a cheap price.
Meanwhile, many pharmaceutical companies led by Roche are protesting strongly against governments in Africa and India over the issue and are also embroiled in legal disputes.
On the one hand, when testing the human body in India. This is not the end. They hid the negative data several times when creating a new drug. Among them are well-known drugs like Tamiflu.
In this case, it is easy to find new drugs with the right drug effects and hidden side effect data. Why are some countries in America, including the United States, so drug-stricken?
If poor blacks and immigrants believe they have become that way by selling drugs, they are still naive about the world. The books that reveal that all multinational pharmaceutical companies are gangsters are now circulating in bookstores like public essays.
Aizen is on the clean side. No, he probably thinks he's clean. I've had it in the liver cancer department.
Ryu Young-joon wraps his face with both hands. I don't like both of them. How about starting my own company? I'm sure that I wouldn't be affected by Aizen if I managed it myself. But at least five years would be wasted.
The reason is, the registration and preparation of research institutions is not so difficult. The government does not give permits easily because of dangerous substances that cannot be handled by the government.
Let's change the way
There are no good pharmaceutical companies. This is because the pharmaceutical companies are all sick.
However, Ryu Young-joon is confident in treating all diseases. Not to mention the political ills that are eating away at pharmaceutical companies. Because Rosalin is here.'
Clik.
Ryu Young-joon deletes the resignation file from his computer. Let's go back to Aizen. There is no better company than there. It takes too long to build a small-to-medium business or startup.
The simplest and most likely way is to directly occupy Aizen and become the largest shareholder who actually controls the company to become CEO.
Kim Hyun-taek, the scientist and other similar politicians in the company had to be exterminated and swallowed up by the giant company. It won't be easy. It can be a fierce political battle and can be the target of many slanders and attacks.
However, Ryu has powerful weapons and plans to defeat them all.
Don't forget Like, Vote, and give us a gift so that Author Retranslate_beginner's spirit-beginner
(☆▽☆)